Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
India flag India · Delayed Price · Currency is INR
3,135.50
+7.70 (0.25%)
Jun 3, 2025, 11:30 AM IST

Torrent Pharmaceuticals Statistics

Total Valuation

NSE:TORNTPHARM has a market cap or net worth of INR 1.06 trillion. The enterprise value is 1.08 trillion.

Market Cap 1.06T
Enterprise Value 1.08T

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date May 23, 2025
Ex-Dividend Date Jun 20, 2025

Share Statistics

Current Share Class 338.45M
Shares Outstanding n/a
Shares Change (YoY) -0.01%
Shares Change (QoQ) +0.15%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 105.92M

Valuation Ratios

The trailing PE ratio is 55.45 and the forward PE ratio is 42.44.

PE Ratio 55.45
Forward PE 42.44
PS Ratio 9.20
PB Ratio 13.96
P/TBV Ratio 35.45
P/FCF Ratio 53.68
P/OCF Ratio 40.99
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.15, with an EV/FCF ratio of 54.95.

EV / Earnings 56.76
EV / Sales 9.42
EV / EBITDA 29.15
EV / EBIT 37.07
EV / FCF 54.95

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.42.

Current Ratio 1.19
Quick Ratio 0.54
Debt / Equity 0.42
Debt / EBITDA 0.86
Debt / FCF 1.62
Interest Coverage 11.61

Financial Efficiency

Return on equity (ROE) is 26.46% and return on invested capital (ROIC) is 16.86%.

Return on Equity (ROE) 26.46%
Return on Assets (ROA) 12.17%
Return on Invested Capital (ROIC) 16.86%
Return on Capital Employed (ROCE) 28.48%
Revenue Per Employee 7.33M
Profits Per Employee 1.22M
Employee Count 15,718
Asset Turnover 0.77
Inventory Turnover 1.15

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +16.24% in the last 52 weeks. The beta is 0.17, so NSE:TORNTPHARM's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change +16.24%
50-Day Moving Average 3,232.13
200-Day Moving Average 3,273.66
Relative Strength Index (RSI) 39.95
Average Volume (20 Days) 350,288

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:TORNTPHARM had revenue of INR 115.16 billion and earned 19.11 billion in profits. Earnings per share was 56.47.

Revenue 115.16B
Gross Profit 87.40B
Operating Income 29.26B
Pretax Income 26.73B
Net Income 19.11B
EBITDA 37.21B
EBIT 29.26B
Earnings Per Share (EPS) 56.47
Full Income Statement

Balance Sheet

The company has 6.91 billion in cash and 32.02 billion in debt, giving a net cash position of -25.11 billion.

Cash & Cash Equivalents 6.91B
Total Debt 32.02B
Net Cash -25.11B
Net Cash Per Share n/a
Equity (Book Value) 75.91B
Book Value Per Share 224.22
Working Capital 9.06B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.85 billion and capital expenditures -6.11 billion, giving a free cash flow of 19.74 billion.

Operating Cash Flow 25.85B
Capital Expenditures -6.11B
Free Cash Flow 19.74B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 75.89%, with operating and profit margins of 25.41% and 16.59%.

Gross Margin 75.89%
Operating Margin 25.41%
Pretax Margin 23.21%
Profit Margin 16.59%
EBITDA Margin 32.31%
EBIT Margin 25.41%
FCF Margin 17.14%

Dividends & Yields

This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 1.02%.

Dividend Per Share 32.00
Dividend Yield 1.02%
Dividend Growth (YoY) 14.29%
Years of Dividend Growth 1
Payout Ratio 56.67%
Buyback Yield 0.01%
Shareholder Yield 1.02%
Earnings Yield 1.80%
FCF Yield 1.86%
Dividend Details

Stock Splits

The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.

Last Split Date Jul 8, 2022
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score n/a